You are here

Brainstorm Award

Objective

The objective of the Brainstorm Awards is to foster interdisciplinary collaborations encompassing novel, hypothesis-driven studies of cancer or a cancer-related topic. The proposed project must be a joint, collaborative effort by at least two Cancer Center members from different programs or different disciplines, and must represent a new collaborative proposal. The Masonic Cancer Center is especially interested in Brainstorm Award applications that are focused on projects relevant to solid tumor oncology with translational potential. Projects that meet these criteria will be prioritized for funding, although it is not a prerequisite for application submission.

Grant Program Contacts

All questions related to the application process, requirements, or eligibility should be directed to:Jessica Raines-JonesResearch Development Coordinator612-624-8679mccgrant@umn.edu

Any questions regarding the applicability of research should be directed to:Anja Bielinsky, PhDbieli003@umn.edu

2016

Tumor-infiltrating Eosinophils: A Protective Role in Colorectal CancerAnna Prizment, PhD, Epidemiology and Community Health, School of Public HealthRobert Cormier, PhD, Department of Biomedical Sciences, Medical School, UMD

The Development of a PEG10 Promoter Driven Theranostic for Castration-Resistant Prostate CancerAaron LeBeau, PhD, Department of Pharmacology, Medical SchoolGregory Metzger, PhD, Department of Radiology, Medical School

2014

A Paradoxical Role for Hypoxia-Inducible Factor Signaling in Pancreas CancerPaolo Provenzano, PhD, Department of Biomedical Engineering, College of Science and EngineeringAnindya Bagchi, PhD, Department of Urology, Medical School

Development of Novel Monocarboxylate Transporter-1 Inhibitors for the Treatment of GliomasLester Drewes, PhD, Department of Biomedical Sciences, Medical School, UMDVenkatram Mereddy, PhD, College of Pharmacy, UMD

2011

Mechanism of Action and Prodrugs of RITA, a Small Molecule for MLL LeukemiasRobert Fecik, PhD, Department of Medicinal Chemistry, College of PharmacyJohn Kersey, MD, Department of Laboratory Medicine and Pathology, Medical School

Integration of Docetaxel into Nanorings for the Treatment of Prostate CancerCarston Wagner, PhD, Department of Medicinal Chemistry, College of PharmacyGunda Georg, PhD, Department of Medicinal Chemistry, College of Pharmacy